Published in Gene Therapy Weekly, December 18th, 1995
Stem cells have been genetically engineered with tumor-specific receptors and successfully transplanted in mice where they produce a variety of immune cells that selectively and efficiently destroy cancer cells. The work was carried out by a team of scientists at Cell Genesys led by Margo Roberts, Ph.D. and was reported at the American Society of Hematology annual meeting, held in Seattle, Washington.
The presentation describes in vivo...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.